🇺🇸 FDA
Pipeline program

recombinant human growth hormone

395779225

Phase 2 small_molecule completed

Quick answer

recombinant human growth hormone for Phelan-McDermid Syndrome is a Phase 2 program (small_molecule) at Affiliated Hospital of Jiangnan University with 1 ClinicalTrials.gov record(s).

Program details

Company
Affiliated Hospital of Jiangnan University
Indication
Phelan-McDermid Syndrome
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials